Germany approved four COVID19 Vaccines that safe and effective

COVID-19 vaccinations are being administered nationwide. Currently, the aim is to protect the most vulnerable first. Vaccinations have already eased the strain on hospitals. Four vaccines have now been approved.

March 16, Berlin: Since the vaccination campaign was launched at the end of December 2020, a total of 8,863,270 people have been vaccinated (as of 13 March). 2,749,786 people have already received both injections.

The aim at the moment is to protect the weakest. Residents and staff of care and nursing homes and everyone over the age of 80 is in the top priority Group 1. People over the age of 70, people with pre-existing conditions, and nursery and primary school teachers are in Group 2, which is the second-highest priority group for vaccination.

Vaccination regulations: this is the order in which COVID-19 vaccinations will be offered

Group 1, including over-80-year-olds, residents of nursing and care homes, employees in intensive care units and accident and emergency, ambulance crews.
Group 2, including 70-80-year-olds, people with Trisomy 21, dementia sufferers, transplant patients, certain contact people
Group 3, including 60-70-year-olds, people with pre-existing conditions, police and fire brigade, nursery and school staff and people working in the retail trade

Vaccinations are having an impact

Where people are vaccinated, the incidence is significantly lower, especially among the over-80-year-olds, says Lothar Wieler, President of the Robert Koch Institute. The number of patients in intensive care is declining slowly, as is the number of deaths. But there are still too many deaths. For about two weeks now the incidence has been rising again in people under the age of 80, states Lothar Wieler.

The RKI President also notes that all vaccines currently available in Germany provide extremely good protection against a severe outcome following infection with variants of the virus. Studies of the AstraZeneca vaccine, for instance, demonstrate a high level of protection for people over the age of 65 as well. “If you are offered a vaccine, please take it. The vaccines are approved. They are safe and they are effective,” he declared.

Vaccines have passed all safety and efficacy tests

The AstraZeneca vaccine has gone through the regular approval procedures of the European Medicines Agency and has passed all required safety and efficacy tests, as have the other vaccines currently authorised within the EU, which are manufactured by BioNTech/Pfizer, Moderna and Johnson & Johnson.

Four vaccines are approved for use

In the EU, four vaccines have now been approved. In December the vaccine manufactured by BioNTech/Pfizer was the first to be approved. At the beginning of January, conditional market authorisation was granted to the Moderna vaccine, followed by the AstraZeneca vaccine on 29 January. On 11 March the Johnson & Johnson was approved for use in the EU. Here you will find an overview of progress on approving COVID-19 vaccines.

General practitioners to offer vaccinations as the next stage

Currently, most vaccinations are offered at vaccination centres and by mobile teams, which are visiting institutions like care and nursing homes. Apart from individual pilot projects, general practitioners have not yet begun to offer vaccinations.

The latest vaccination regulations dated 10 March put in place the basis for general practitioners to offer vaccinations. This will be launched as soon as sufficient numbers of vaccine doses are available. Talks between the federal and state governments are ongoing.

Contracts for around 300 million vaccine doses

If all vaccination candidates are approved for use, Germany will expect to receive a total of 300 million doses. This figure includes the number of doses that Germany will receive under the contracts concluded by the EU as well as the vaccination doses agreed with German manufacturers who have received German government funding.